PIK3CA and neoplasm: We found that MSI, BRAF mutation status, site, mucinous histology and expression of p53 were significantly associated with various subtypes (Figure 3), but not tumour stage, age, gender, SMAD4 or PIK3CA mutations (see Supplementary material, Figure S5A).